EUVIMEDEUVIMED entdecken
Crossref

Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study

Ahuva Cices, Nour El-Kashlan, Bridget Kaufman, Joel Correa Da Rosa, Ingrid Sanabria-Gonzalez, Saakshi Khattri, Andrew Alexis

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.8962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Ahuva Cices und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thalidomide, Alopecia, Anti-Inflammatory Agents, Non-Steroidal, Cicatrix.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThalidomideAlopeciaAnti-Inflammatory Agents, Non-SteroidalCicatrixHumansFemalePilot ProjectsAdultTreatment OutcomeMiddle AgedSeverity of Illness IndexAdministration, OralPatient Reported Outcome Measures

Substanzen

apremilastThalidomideAnti-Inflammatory Agents, Non-Steroidal

Zitieren

APA

Cices, A., El-Kashlan, N., Kaufman, B., Rosa, J. C. D., Sanabria-Gonzalez, I., Khattri, S., & Alexis, A. (2025). Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.8962

Vancouver

Cices A, El-Kashlan N, Kaufman B, Rosa JCD, Sanabria-Gonzalez I, Khattri S, et al. Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.8962

BibTeX
@article{Cices2025,
  author = {Cices, Ahuva and El-Kashlan, Nour and Kaufman, Bridget and Rosa, Joel Correa Da and Sanabria-Gonzalez, Ingrid and Khattri, Saakshi and Alexis, Andrew},
  title = {Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia: An Open-Label Pilot Study},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.8962}
}
Kostenlos starten →